PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
11-Jun-2020 Ethos, a new company, launched to re-define compliance training in a digital age Ethos Pharmaceutical Ethics and Compliance Limited
11-Jun-2020 Quell Therapeutics strengthens its Board with the appointments of Dr Dhaval Patel and Sir Robert Lechler and hires Dr Natalie Belmonte as SVP Research & Translation Quell Therapeutics
11-Jun-2020 Bone Therapeutics announces Annual General Meeting results and confirms outlook for 2020 Bone Therapeutics
11-Jun-2020 Zelluna Immunotherapy raises funds to fully focus on developing allogeneic “off-the-shelf” TCR based Natural Killer (TCR-NK) cell therapies About Zelluna Immunotherapy
11-Jun-2020 Alnylam Announces Publication of ENVISION Phase 3 Study Results for Givosiran in The New England Journal of Medicine Alnylam Pharmaceuticals, Inc.
11-Jun-2020 Ethos, a new company, launched to re-define compliance training in a digital age Ethos
11-Jun-2020 Trending News – Emergency Medical Services Products Market Outlook 2020, Impact of COVID-19, Size, Share till 2025 Expert Market Research
10-Jun-2020 The Creative Engagement Group acquires Cormis healthcare consultancy The Creative Engagement Group
08-Jun-2020 WORLD EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET RESEARCH REPORT 2025, COVID BUSINESS IMPACT INFORMATION COVERED The Holistic Reports
08-Jun-2020 AstraZeneca to lead workshop at Wearable Injectors and Connected Devices Conference 2020 SMi Group Ltd
08-Jun-2020 Press Launch of hVIVO COVID Clear Test, the most accurate antibody test available to UK employers to help get people back to work hVIVO
08-Jun-2020 UCB Shares Breadth of Innovative New Data from Rheumatology Portfolio for EULAR 2020 E-Congress UCB
08-Jun-2020 AbbVie at EULAR - RINVOQ™ (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Head-to-Head Study Versus ORENCIA (abatacept) in Rheumatoid Arthritis Patients AbbVie
08-Jun-2020 Sanofi to present Phase 3 results of avalglucosidase alfa in patients with late-onset Pompe disease Sanofi
08-Jun-2020 US FDA Grants Mexiletine Orphan Drug Designation Lupin
08-Jun-2020 Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre Oxford Biomedica plc
08-Jun-2020 Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre Oxford Biomedica
08-Jun-2020 Achilles Therapeutics to set up manufacturing operations at the CGT Catapult manufacturing centre Achilles Therapeutics
08-Jun-2020 Achilles Therapeutics to set up manufacturing operations at the CGT Catapult manufacturing centre The Cell and Gene Therapy Catapult
08-Jun-2020 First adjuvanted quadrivalent influenza vaccine receives EU approval Seqirus